Disseminated BCG sepsis following intravesical therapy for Bladder Carcinoma: A case report and review of literature

• Main Authors: Oreoluwa Oladiran (Author), Ifeanyi Nwosu (Author), Adeolu Oladunjoye (Author), Olubunmi Oladunjoye (Author)
• Format: Book
• Published: Greater Baltimore Medical Center, 2020-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 2000-9666; 10.1080/20009666.2020.1742475
• Keywords: bacillus calmette-guérin; bcg; sepsis; bladder tumor; Internal medicine; RC31-1245
• Source: Journal of Community Hospital Internal Medicine Perspectives, Vol 10, Iss 2, Pp 168-170 (2020)

Intravesical instillation of Bacillus-Calmette-Guerin (BCG), a live-attenuated-strain of Mycobacterium bovis, is an established treatment for superficial bladder carcinoma. Although generally well tolerated, 1/15,000 patients can develop life-threatening disseminated-BCG-infection typically soon after the procedure, a condition colloquially termed BCG-osis. Side-effects of intravesical BCG instillation including fever, chills, fatigue are common but BCG-osis is rare and severe, oftentimes requiring intensive care unit admission and triple anti-TB-therapy as in this case. It is therefore important for clinicians to recognize this possibility as the absence of specific signs and symptoms, coupled with the fastidious nature of the Mycobacteria, pose a diagnostic dilemma in the acute setting. Our case highlights this potential rare iatrogenic side effect of intravesical BCG treatment and the risk associated with non-treatment of BCG-osis.